Sign in to view content

Assessing Characteristics of Patients With or Without Intraocular Inflammation (IOI) In the Brolucizumab Treatment Arms From the HAWK and HARRIER, Phase 3 Studies

Jeffrey S. Heier, MD

Video
Published 2020

Related

Outcomes of Children With Autosomal Dominant Neovascular Inflammatory Vitreoretinopathy
Arjun B Sood, MD
Annual Meeting Talks
2023
Single Intraoperative Subconjunctival Triamcinolone Acetonide Injection Versus 4-6-Week Topical Steroid Taper Following Vitreore
Elizabeth A Atchison, MD
Updates from the Field
2018
Commercial OCT Enters the Cellular Age – Tracking Macrophage Surveillance of the Macula Circulation!
Richard B. Rosen, MD, DSc(Hon), FACS, FASRS, FARVO
Annual Meeting Talks
2021

Category: Age-Related Macular Degeneration

See more